OTC:GWLL | Cash Flow Statement | GOLDENWELL BIOTECH, INC.

Complete source-backed cash-flow history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$36,876.00
2026-03-31-$17,606.00-$13,361.00$0.00
2025-12-31-$248,890.00-$18,848.00$0.00
2025-09-30-$7,985.00
2025-06-30-$30,300.00$59,380.00$0.00
2025-03-31-$38,536.00-$32,276.00$0.00
2024-12-31-$27,536.00-$25,351.00$70,000.00
2024-09-30$23,065.00
2024-06-30$49,920.00-$47,751.00$49,250.00
2024-03-31$30,977.00-$29,010.00$2,100.00
2023-12-31-$21,265.00-$19,076.00$60,388.00
2023-09-30-$35,406.00-$35,210.00$30,000.00
2023-06-30-$27,084.00-$26,946.00
2023-03-31-$33,606.00-$31,921.00$30,000.00
2022-12-31-$920,333.00-$917,090.00
2022-09-30-$4,584.00$15,222.00
2022-06-30-$26,800.00-$25,037.00$0.00
2022-03-31-$33,380.00-$145,655.00
2021-12-31-$99,225.00-$19,373.00$0.00
2021-09-30-$87,441.00-$12,506.00
2021-06-30-$23,584.00-$150,201.00$170,125.00
2021-03-31-$46,101.00-$150,200.00$170,125.00
2020-12-31-$2,975.00-$2,975.00$1,000.00
2020-09-30-$879.00
2020-06-30-$141.00
2020-03-31-$2,329.00-$2,329.00$7,300.00
2019-12-31-$323.00-$2,311.00$248,904.00
2019-09-30-$1,988.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$296,471.00-$22,629.00$0.00
2024-12-31-$131,498.00-$123,077.00$119,250.00
2023-12-31-$117,361.00-$113,153.00$120,388.00
2022-12-31-$985,097.00-$1.07M$905,000.00
2021-12-31-$116,981.00-$205,138.00$170,125.00
2020-12-31-$6,324.00-$6,324.00$8,300.00
2019-12-31-$2,311.00-$2,311.00$248,904.00